上海交通大学：《药物化学》课程教学资源（课后题库）Chapter 8 Drugs for Metabolic Syndrome Treatment

1.Incretin GLP-1:(I)is activated by dipeptidyl peptidase-4(DPP-4),(II)stimulates the release of insulin,(III)inhibits glucagon release. Answer:(a)I only,(b)III only,(c)I and II only,(d)II and III only,(e)I,II and III 2.Semilente Insulin:(I)has an extended duration of action,(II)cannot be used for type 1 diabetics, (III)has a short duration of action. Answer::(a)I only,(b)ⅢI only,(c)IandⅡonly,(d)Ⅱand III only,.(e)L,Ⅱandl 3.Orlistat is:(I)a non-stimulant weight loss agent,(II)a potent reversible inhibitor of pancreatic lipase,(III)a drug derived from the natural product Lipstatin. Answer:(a)I only,(b)III only,(c)I and II only,(d)I and III only,(e)I,II and III

1. Incretin GLP-1: (I) is activated by dipeptidyl peptidase-4 (DPP-4), (II) stimulates the release of insulin, (III) inhibits glucagon release. Answer: (a) I only, (b) III only, (c) I and II only, (d) II and III only, (e) I, II and III 2. Semilente Insulin: (I) has an extended duration of action, (II) cannot be used for type 1 diabetics, (III) has a short duration of action. Answer:(a) I only, (b) III only, (c) I and II only, (d) II and III only, (e) I, II and III 3. Orlistat is: (I) a non-stimulant weight loss agent, (II) a potent reversible inhibitor of pancreatic lipase, (III) a drug derived from the natural product Lipstatin. Answer: (a) I only, (b) III only, (c) I and II only, (d) I and III only, (e) I, II and III